The latest trading session saw Sensus Healthcare, Inc. (SRTS) ending at $6.77, denoting a +1.96% adjustment from its last day's close. The stock's performance was ahead of the S&P 500's daily gain of 1.83%. Meanwhile, the Dow experienced a rise of 1.65%, and the technology-dominated Nasdaq saw an increase of 2.45%.
Coming into today, shares of the company had lost 14.65% in the past month. In that same time, the Medical sector lost 3.48%, while the S&P 500 lost 3.31%.
The investment community will be closely monitoring the performance of Sensus Healthcare, Inc. in its forthcoming earnings report. The company is expected to report EPS of $0.10, down 61.54% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $9.86 million, reflecting a 21.6% fall from the equivalent quarter last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sensus Healthcare, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Currently, Sensus Healthcare, Inc. is carrying a Zacks Rank of #2 (Buy).
Investors should also note Sensus Healthcare, Inc.'s current valuation metrics, including its Forward P/E ratio of 9.35. This expresses a discount compared to the average Forward P/E of 28.72 of its industry.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 57, putting it in the top 23% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Free Today: Profiting from The Future’s Brightest Energy Source
The demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.
Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.
Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.
Download Atomic Opportunity: Nuclear Energy's Comeback free today.Sensus Healthcare, Inc. (SRTS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
